NeurologyLive® Friday 5 — November 1, 2024

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Advancing Alzheimer Treatment Through Gamma Oscillation Stimulation: Ralph Kern, MD, MHSc

The chief medical officer at Cognito Therapeutics talked about a medical device designed to slow cognitive decline in patients with Alzheimer disease through gamma frequency brain stimulation. [WATCH TIME: 6 minutes]

2: Enhancing Stroke Prevention Guidelines Through Diverse Evidence and Inclusive Care: Cheryl D. Bushnell, MD, MHS, FAHA

The professor of neurology at Wake Forest University School of Medicine discussed the importance of expanding the diversity of clinical trial populations, considering the impact of social determinants of health, and ensuring accessibility for high-risk underserved groups. [WATCH TIME: 4 minutes]

3: NeurologyLive® Clinician of the Month Spotlight: Sana Aslam, DO

As part of our monthly clinician spotlight, NeurologyLive® highlighted movement disorder expert Sana Aslam, DO, an assistant professor of neurology at University of Colorado School of Medicine.

4: NeuroVoices: Anne Marie Morse, DO, FAASM, on the Impact of the Once-Nightly Sodium Oxybate Approval for Pediatric Narcolepsy

In our latest Q&A for NeuroVoices, the director of Child Neurology and Pediatric Sleep Medicine at Geisinger Janet Weis Children's Hospital talked about how the recent approval of once-nightly sodium oxybate for pediatric narcolepsy enables more effective and manageable treatment options for children and families.

5: Exploring The Challenges and Insights in Long COVID Treatment and Management

Without a specific tailored Long COVID therapy, individualized treatment based on patient phenotypes, along with extensive evaluations, is essential for effective symptom management.